Identification of Diseases that may be Targets for Complementary and Alternative Medicine (CAM)

  • Aristo Vojdani
  • Edwin L. Cooper
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 546)


Complementary and alternative medicine has an enormous challenge to determine how environmental factors such as infection and xenobiotics interact. Effective strategies for early detection, diagnosis, prevention and therapy should then emerge. Despite significant advancements in medicine and discovery of human genome, little attention has been paid to early diagnosis and prevention of complex diseases. Diseases such as Crohn’s, ulcerative colitis, cardiovascular, autoimmune, cancer, diabetes and others are multifactorial, meaning that they cannot be ascribed to mutation in a single gene or to a single environmental factor. Rather they arise from the combined action of many genes, environmental factors such as infection, xenobiotics and risk-conferring behaviors (Kimberstis and Roberts, 2002). Com-plex diseases have reached epidemic proportions in the United States and in a particularly disturbing trend, striking at a young age. With this explosion, we should be committed to expanding the approach to healing. This opens classical approaches to complementary and alternative therapies.


Multiple Sclerosis Ulcerative Colitis Experimental Autoimmune Encephalomyelitis Food Allergy Infectious Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aoki T, Usuda Y, Miyakoshi H, Tamura K and Herberman RB, 1987, Low natural killer syndrome: clinical and immunological features. Nat. Immun. Cell Growth Regul. 6:116–128.PubMedGoogle Scholar
  2. Bariety J, Druet P, Laliberte F and Sapin C, 1971, Glomerulonephritis with γ- and 1C-globulin deposits induced in rats by mercuric chloride. Am. J. Pathol. 65:293–297.PubMedGoogle Scholar
  3. Bengmark S, 1996, Econutrition and health maintenance — a new concept to prevent GI inflammation, ulceration and sepsis. Clin. Nutr. 15:1–10.PubMedCrossRefGoogle Scholar
  4. Bronze MS and Dale JB, 1993, Epitope of streptococcal M. proteins that evoke antibodies that cross-react with the human brain. J. Immunol. 151:2820–2828.PubMedGoogle Scholar
  5. Caselli E, Boni M, Bracci A, Rotola A, Cermelli C, Castellazi M, Di Luca D and Cassai E, 2002, Detection of antibodies directed against human herpesvirus-6 U 94/REP in sera of patients affected by multiple sclerosis. .J. Clin. Microbiol. 40:4131–4137.PubMedCrossRefGoogle Scholar
  6. Cataldo F, Marwo V, Ventura A, Bottaro G and Corazza GR, 1998, Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicenter study. Gut 42:362–365.PubMedCrossRefGoogle Scholar
  7. Caygill CPJ, Charlett A and Hill MJ, 1998, Relationship between the intake of high-fibre foods and energy and the risk of cancer of the large bowel and breast. Eur. J. Cancer Prey. 7:S11–17.CrossRefGoogle Scholar
  8. Challoner PB, Smith KT and Parker JD, 1995, Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. USA 92:7440–7444.PubMedCrossRefGoogle Scholar
  9. Cole SR, Beck RW, Moke PS, Kaufman DI and Tourtellotte WW, 1998, The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis. Neurology 51:885–887.PubMedCrossRefGoogle Scholar
  10. Crotty B, 1994, Ulcerative colitis and xenobiotic metabolism. Lancet 343, 35–38.PubMedCrossRefGoogle Scholar
  11. Das KM, Dasgupta A, Mandal A and Geg X, 1993, Autoimmunity to cytoskeletal protein Tropomyosin. J. Immunology 150:2487–2495.Google Scholar
  12. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken E and Schuppan D, 1997, Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Medicine 3:797–801.PubMedCrossRefGoogle Scholar
  13. Dupont C, Barau E, Molkhou P, Raynaud F, Barbet JP and Dehennin L, 1989, Food-induced alterations of intestinal permeability in children with cows’ milk-sensitive enteropathy and atopic dermatitis. J. Ped. Gastroentero Nutr. 8:459–465.CrossRefGoogle Scholar
  14. Esposito M, Venkatesh V, Otvos L, Weng Z, Vajda S, Banki K and Perl A, 1999, Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients. J. Immunology 163:4027–4032.Google Scholar
  15. Fatemi SH, Earle J, Kamodia R, Kist D, Emamian ES and Patterson PH, 2002, Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell. Mol. Neurobiol. 22:25–33.PubMedCrossRefGoogle Scholar
  16. Fernandez-Gutierrez B, Hernandez-Garcia C, Banares AA and Jover JA, 1995, Characterization and regulation of CD69 expression on rheumatoid arthritis synovial fluid T- cells. J. Rheumatol. 22:413.PubMedGoogle Scholar
  17. Frei B, Stocker R and Ames BN, 1988, Anti-oxidant defenses and lipid peroxidation in human blood plasma. Prod. Natl. Acad. Sci. USA 86:6377–6381.CrossRefGoogle Scholar
  18. Gann PH, Ma J, Giovannucci E, Willet T, Sacks FM, Hennekens CH and Stampfer MJ, 1999, Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 59:1225–1230.PubMedGoogle Scholar
  19. Garewal H, 1995, Antioxidants in oral cancer prevention. Am. J. Clin. Nutr. 62:1410–14165.Google Scholar
  20. Giulian D and Corpuz M, 1993, Microglial secretion products and their impact on the nervous system. Adv. Neurol. 59:315–321.PubMedGoogle Scholar
  21. Greenwald P, 1996, Chemoprevention of cancer. Scientific American 275:96–99.PubMedCrossRefGoogle Scholar
  22. Greenwald P, Kellof G, Burch-Whitman C and Kramer BS, 1995, Chemoprevention. CA Cancer J. Clin. 45: 31–49.PubMedCrossRefGoogle Scholar
  23. Griem P, Wulferink M, Sachs, Gonzalez JB and Gleichmann E, 1998, Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunology Today 19:133–142.PubMedGoogle Scholar
  24. Grogan JL, Kramer A, Nogai A, Dong L, Ohde M, Schneider-Mergener J, et al., 1999, Cross-reactivity of myelin basic protein-specific T- cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice. J. Immunol. 163:3764–3770.PubMedGoogle Scholar
  25. Gronseth GS and Ashman EJ, 2000, Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1720–1725.PubMedCrossRefGoogle Scholar
  26. Hadjivassiliou M, Boscolos S, Davies-Jones GAB, et al., 2002, The humoral response in the pathogenesis of gluten ataxias. Neurology 58:1221–1226.PubMedCrossRefGoogle Scholar
  27. Hamann J, Fiebig H and Strauss M, 1993, Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain. J. Immunol. 150:4920.PubMedGoogle Scholar
  28. Heyman M, Grasset E, Ducroc R and Desjeux JF, 1988, At absorption by the jejunal epithelium of children with mild allergy. Pediatr Res. 24:197–202.PubMedCrossRefGoogle Scholar
  29. Hildrebrandt M, Reutter W, Archk P, Rose M and Klapp B, 2000, A guardian angel: the involvement of Dipep-tidylpeptidase IV in psychoneuroendocrine function, nutrition and immune defense. Clin. Sci. 99:93–98.CrossRefGoogle Scholar
  30. Hirsch F, Couderc J, Sapin C, Fournie G and Druet P, 1982, Polyclonal effect of HgCL2 in the rat, its possible role in an experimental autoimmune disease. Eur. J. Immunol. 12:620–626.PubMedCrossRefGoogle Scholar
  31. Hopper LV, Wong MH, Thelin A, Hansson L, Falk PG and Gordon JI, 2001, Molecular analysis of commensal host-microbial relationship in the intestine. Science 291:881–884.CrossRefGoogle Scholar
  32. Hu S, Chao CC, Khanna KV, Gekker G, Peterson PK and Molitor TW, 1996, Cytokine and free radical production by prcine microglia. Clin. Immunol. Immunopathol. 78:93–98.PubMedCrossRefGoogle Scholar
  33. Iannone F, Corrigal VM and Panayi GS, 1996, CD69 on synovial T- cells in rheumatoid arthritis correlates with disease activity. Br. J. Rheumatol. 35:397–401.PubMedCrossRefGoogle Scholar
  34. Iijima H, Takahashi I, Kiyono H, 2001, Mucosal immune network in the gut for control of infectious diseases. Rev. Med. Virol. 2:117–133.CrossRefGoogle Scholar
  35. Ito K, Takaishi H, Jin Y, Song F, Denning TL and Ernst PB, 2001, Staphylococcal enterotoxins B stimulates expansion of autoreactive T- cells that induce apoptosis in intestinal epithelial cells: regulation of autoreactive responses by IL-10. J. Immunl. 164:2994–3001.Google Scholar
  36. Ivarsson SA, Bjerre L, Vegfors P and Ahlfors K, 1990, Autism as one of several abnormalities in two children with congenital cytomegalovirus infection. Neuropediatrics 21:102–103.PubMedCrossRefGoogle Scholar
  37. Jackson PG, Baker RW, Lessof MH, Ferret J and MacDonald DM, 1981, Intestinal permeability in patients with eczema and food allergy. Lancet 1:1295–1286.Google Scholar
  38. Jalonen T, 1991, Identical intestinal permeability change children with different clinical manifestation of cow’s milk allergy. J. All. Clin. Immunol. 88:37–742.CrossRefGoogle Scholar
  39. Kameoka J, Tanaka T, Nojima Y, Schlossman SF and Morimoto C, 1993, Direct association of adenosine deaminase with a T- cell activation antigen CD26. Science 261:466–470.PubMedCrossRefGoogle Scholar
  40. Kiberstis P and Roberts L, 2002, It’s not just the genes. Science 296:685–686.CrossRefGoogle Scholar
  41. Kohl A, Bourcier T, Lichtman AH, et al., 1991, Chlamydia and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells and macrophages. J. Clin. Invest. 103:571–577.CrossRefGoogle Scholar
  42. Kono DH, Park MS, Szydlik A, Haraldsson KM, Duan JD and Pearson DL, 2001, Resistance to xenobiotic-induced autoimmunity maps to chromosome 1. Immunol. 167:2396–2403.Google Scholar
  43. Lenz DC, Lu L, Conant SB, Wolf NA, Gerard HC and Whittum-Hudson JA, 2001, A Chlamydia pneumoniae-specific peptide induces experimental autoimmune encephalomyelitis in rats. J. Immunol. 167:1803–1808.PubMedGoogle Scholar
  44. Levin MC, Lee SM, Klaume F, et al., 2002, Autoimmunity due to molecular mimicry as a cause of neurological disease. Nature Medicine 8:509–513.PubMedCrossRefGoogle Scholar
  45. Levine M, Conry-Cantilena C, Wang Y, et al., 1996, Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc. Natl. Acad. Sci. USA 93:3704–3709.PubMedCrossRefGoogle Scholar
  46. Majama H and Isolauri E, 1990, Evaluation of the gut mucosal barrier for increased antigen transfer in children with atopic eczema. J. All. Clin. Immunol. 97:985–990.CrossRefGoogle Scholar
  47. Marshal E, 2002, Lupus: mysterious disease holds it secrets tight. Science 29:689–691.CrossRefGoogle Scholar
  48. Marshall JC, Christou NV and Meakins JL, 1988, Immunomodulation by altered gastrointestinal tract flora. Arch Surg. 123:1465–1469.PubMedCrossRefGoogle Scholar
  49. Martin R, Gran B, Zhae Y, et al., 2001, Molecular mimicry and antigen-specific T- cell. J. Autoimmunity 16: 187–92.CrossRefGoogle Scholar
  50. Marx J, 2002, Unraveling the causes of diabetes. Science 296:686–689.PubMedCrossRefGoogle Scholar
  51. McIntyre KW and Welsh RM, 1986, Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection. J. Exp. Med. 164:1667–1681.PubMedCrossRefGoogle Scholar
  52. Miller, DH, Grossman RI, Reingold SC, 1998, The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 121, 3–24.PubMedCrossRefGoogle Scholar
  53. Misumi Y, Hayashi Y, Arakawa F and Ikehara Y, 1992, Molecular cloning and sequence analysis of hu-man dipeptidylpeptidase IV, a serine proteinases on the cell surface. Biochem. Biophys. Acta. 1131:333–336.PubMedCrossRefGoogle Scholar
  54. Mowat A, 2003, Anatomical basis of intolerance and immunity to intestinal antigens. Nature Reviews Immunology 3:331–340.PubMedCrossRefGoogle Scholar
  55. Muhlestein JB, 1998, Chronic infection and coronary artery disease. Sci. Med. Nov/Dec, 16–25.Google Scholar
  56. Muscat C, Bertotto A, Agea E, Bistoni O, Ercolani R, Tognelli R, et al., 1994, Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid cells in rheumatoid arthritis patients. Clin. Exp. Immunol. 98:252–256.PubMedCrossRefGoogle Scholar
  57. Noronha A and Arnanson B, 1995, Demyelinating diseases. In: Rich, Fleisher, Schwartz, Shearer and Strober, eds. Clinical Immunology pp. 364–1375. Mosby.Google Scholar
  58. Noseworthy JH, Lucchinetti C, Rodriquez M and Weinshenker BJ, 2000, Multiple sclerosis, a review. New England Journal of Medicine 343:938–952.PubMedCrossRefGoogle Scholar
  59. Olson JK, Eagar TN and Miller SD, 2002, Functional activation of myelin-specific T- cells by virus-induced mimicry. J. Immunol. 169:2719–2726.PubMedGoogle Scholar
  60. Phillip A and Mackowiak MD, 1982, The normal microbial flora, medical progress section. New Engl. J. Med. 307:83–93.CrossRefGoogle Scholar
  61. Phillips DIM and Matthews N, 1987, The measurement of antibodies to C. albicans as a screening test for humoral deficiencies. J. Immunol. Methods 105:127–131.PubMedCrossRefGoogle Scholar
  62. Pohl LR, Satoh H, Christ DD and Kenna JG, 1988, The immunological and metabolic basis of drug hypersensi-tivities. Annu. Rev. Pharmacol. Toxicol. 28:367–387.PubMedCrossRefGoogle Scholar
  63. Pollack M, Ohl CA, Goldenbock DT, 1997, Dual effects of LPS antibodies on cellular uptake of LPS and LPS-induced pro-inflammatory functions. J. Immuno. 159:3519–3530.Google Scholar
  64. Podmore ID, Griffiths HR and Herbert KE, 1998, Vitamin C exhibits pro-oxidant properties, Nature 392: 559–560.PubMedCrossRefGoogle Scholar
  65. Prasad KN, Edwards-Prasad J, Kumar S, et al., 1993, Vitamins regulate gene expression and induce differentiation and growth inhibition in cancer cells: their relevance in cancer prevention. Arch. Otolaryngol. Head Neck Surg. 119:1133–1140.PubMedCrossRefGoogle Scholar
  66. Pross HF and Lotzova E, 1993, Role of natural killer cells in cancer. Nat. Immunol. 12:279–292.Google Scholar
  67. Quinton JF, Charrier G, Colombel JF, Sendid B, Poulain D, Grandbastien B, Reumaux D, Duthilleul P and Targan SR, 1998, Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42:788–791.PubMedCrossRefGoogle Scholar
  68. Raine CS, Cannella B, Hauser SL and Genain CP, 1999, Demyelination in primate autoimmune encephalomyeli-tis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 46: 144–160.PubMedCrossRefGoogle Scholar
  69. Ridker PM, 1999, Evaluating novel cardiovascular risk factors: can we better predict heart attack? Ann. Intern. Med. 130:933–937.PubMedCrossRefGoogle Scholar
  70. Ridker PM, Hennekens CH, Buring JE et al., 2000, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Eng. J. Med. 342:836–843.CrossRefGoogle Scholar
  71. Rees J, 2002, Complex disease and the new clinical sciences. Science 296:698–701.PubMedCrossRefGoogle Scholar
  72. Robinson CJ, Abraham AA and Balazs T, 1984, Induction of anti-nuclear antibodies by mercuric chloride in mice. Clin. Exp. Immunol. 58:300–307.PubMedGoogle Scholar
  73. Roman-Franco AA, Turiello M, Albini B, Ossi E, Milgrom F and Andres GA, 1978, Anti-basement membrane antibodies and antigen-antibody complexes in rabbits injected with mercuric chloride. Clin. Immunol. Im-munopathol. 9:464–470.CrossRefGoogle Scholar
  74. Salama A, Schutz B, Kietel V, Breithaupt H and Mueller-Eckhardt C, 1989, Immune-mediated agranulocytosis related to drugs and their metabolites:mode of sensitization and heterogeneity of antibodies. Br. J. Haematol. 72:127–132.PubMedCrossRefGoogle Scholar
  75. Sblattero D, Berti I and Trevisiol C, 2000, Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am. J. Gastroenterol. 95:1253–1257.PubMedCrossRefGoogle Scholar
  76. Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM and Khosla C, 2002, Structural basis for gluten intolerance in Celiac Sprue. Science 297:2275–2279.PubMedCrossRefGoogle Scholar
  77. Shi HN, Liu HY and Nagler-Anderson, 2000, Enteric infection as an adjuvant for the response to a model food antigen. J. Immunol. 166:6174–6182.Google Scholar
  78. Shi L, Fatemi SH, Sidwell RW and Patterson PH, 2003, Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosciences 23:297–302.Google Scholar
  79. Stefferi A, Schubart A, Storch M, Amina A, mather I, Lassman H and Linington C, 2000, Butyrophilin, a milk protein, modulates the encephalitogenic T- cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. J. Immunol. 165:2859–2865.Google Scholar
  80. Steinman L, 1996, Multiple sclerosis: a coordinated myelin attack against myelin in the central nervous system. Cell 85:299–302.PubMedCrossRefGoogle Scholar
  81. Stollberger C and Finsterer J, 2002, Role of infections and immune factors in coronary and cerebrovascular arteriosclerosis. Clin. Diag. Lab. Immunol. 9:207–215.Google Scholar
  82. Strohman R, 2002, Maneuvering in the complex path from genotype to phenotype. Science 296:701–704.PubMedCrossRefGoogle Scholar
  83. Sub-Committee on The 10th Edition of the RDA’s Food and Nutrition Board, commission of Life Sciences, National Research council. Recommended dietary allowances, ed 10. Washington, DC, National Academy Press, 1989:115–124.Google Scholar
  84. Tabeta K, Yamazaki K, Hotokezaka H et al., 2000, Elevated humoral immune response to the heat shock protein 60 (hsp60) family in periodontitis patients. Clin. Exp. Immunol. 120:285–293.PubMedCrossRefGoogle Scholar
  85. Vayssier C, Mayrand D and Grenier D, 1994, Detection of stress proteins in Porphyromonas gingivalis and other oral bacteria by Western immunoblotting analysis. FEMS Microbiol. Lett. 121:303–307.PubMedCrossRefGoogle Scholar
  86. Vojdani A, 1999, A single blood test for detection food allergy, candidiasis, microflora imbalance, intestinal barrier dysfunction and humoral immune deficiencies. Biomedical Therapy 17:129–134.Google Scholar
  87. Vojdani A, 2003, A look at infectious agents as a possible causative factor in cardiovascular disease: part I. Lab. Medicine 34 (3):7–11.Google Scholar
  88. Vojdani A, 2003, A look at infectious agents as a possible causative factor in cardiovascular disease: part II. Lab. Medicine 34 (4):5–9.Google Scholar
  89. Vojdani A, 2003, A look at infectious agents as a possible causative factor in cardiovascular disease: part III. Lab. Medicine 34 (5):24–31.Google Scholar
  90. Vojdani A, Barzagan M, Vojdani E and Wright J, 2000, New evidence for antioxidant properties of Vitamin C. Cancer Detec. And Prey. 24:508–523.Google Scholar
  91. Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K and Vojdani E, 2002, Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J. Neuroimmunol. 129:168–177.PubMedCrossRefGoogle Scholar
  92. Vojdani A, Ghoneum M and Brautbar N, 1992, Immune alteration associated with exposure to toxic chemicals. Toxicol. Ind. Health 8:231–246.PubMedGoogle Scholar
  93. Vojdani A and Ghoneum M, 1993, In vivo effect of ascorbic acid on enhancement of natural killer cell activity. Nutr, Res. 13:753–764.CrossRefGoogle Scholar
  94. Vojdani A and Namatalla G, 1997, Enhancement of human natural killer cell cytotoxic activity by Vitamin C in pure and augmented formula. J. Nutr. Environ. Med. 7:187–195.CrossRefGoogle Scholar
  95. Vojdani A, Pangborn JB, Vojdani E and Cooper EL (in press) Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are responsible for autoimmunity in autism. Int. J. Immunopath. Pharmacol. 16:189–200.Google Scholar
  96. Vojdani, A., Vojdani, E. and Cooper, E., 2003, Antibodies to myelin basic protein, myelin oligodendrocyte peptides, α- β3-crystallin, lymphocyte activation, and cytokine production in patients with multiple sclerosis. J. Internal Medicine 254:1–12.CrossRefGoogle Scholar
  97. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al., 1998, Ileal-lymphoid-noduclar hyperplasia, non-specific colitis, a pervasive developmental disorder in children. Lancet 351:637–641.PubMedCrossRefGoogle Scholar
  98. Walker WA and Isselbacher KJ, 1977, Intestinal antibodies. New Engl. J. Med. 297:767–773.PubMedCrossRefGoogle Scholar
  99. Ware JA, Graf MLM, Bartin BM, Lustberg LR and Pohl LR, 1998, Immunochemical detection and identification of protein adducts of diclofenac in the small intestine of rats</b>: possible role in allergic reactions. Chem. Res. Toxicol. 11:164–171.Google Scholar
  100. Webster AD, Efter T and Asherson GL, 1974, Escherichia coli antibody: a screening test for immunodeficiency. BMJ 3:16–18.PubMedCrossRefGoogle Scholar
  101. Whiteside TL, Bryant J, Day R, et al., 1990, Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J. Clin. Lab. Anal. 4:102–110.PubMedCrossRefGoogle Scholar
  102. Wick G, 1995, Is atherosclerosis an immunologically mediated disease? Immunol. Today 16:27–33.PubMedCrossRefGoogle Scholar
  103. Willett WC, 2002, Balancing life-style and genomics research for disease prevention. Science 296:695–698.PubMedCrossRefGoogle Scholar
  104. Williams GM, Williams CL and Weisburger JH, 1999, Diet and cancer prevention: the fiber first diet. Toxicological Sciences 52:72–86.PubMedGoogle Scholar
  105. Woodland DL, 2002, Immunity and retroviral superantigens in humans trends Immunology 23:57–58.Google Scholar
  106. Wucherpfenning KW, 2002, Infectious triggers for inflammatory neurological diseases. Nature Medicine 8:455–457.CrossRefGoogle Scholar
  107. Xu Q, Willeit J, Marosi M, et al., 1993 Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 341:255–259.PubMedCrossRefGoogle Scholar
  108. Yamazaki K, Ohsawa Y, Tabeta K, et al., 2002, Accumulation of heat shock protein 60-reactive T- cells in the gingival tissues of periodontis patients. Infect. Immun. 70:2492–2501.PubMedCrossRefGoogle Scholar
  109. Yoshida S and Gershwin ME, 1993, Autoimmunity and selected environmental factors of disease induction. Semin Arthritis Rheum. 22:399–405.PubMedCrossRefGoogle Scholar
  110. Yu X, Matsui T, Otsuka M, Senine T, Yamamoto K, Nishioka K, et al., 2001, AntiCD69 autoantibodies cross-react with low density lipoprotein receptor-related protein 2 in systemic autoimmune diseases. J. Immunol. 166:1360–1369.PubMedGoogle Scholar
  111. Zhang S, Hunter DJ, Forman MR, Rosner BA, Speizer FE, Colditz GA, Manson JE, Hankinson SE and Willet WC, 1999, Dietary carotenoids and Vitamins A, C, and E and the risk of breast cancer. J. Natl. Cancer Inst. 91:547–556.PubMedCrossRefGoogle Scholar
  112. Zhou YF, Shou M, Harrell RF et al., 2000, Chronic non-vascular cytomegalovirus infection: effects on the neoin-timal response to experimental vascular injury. Cardiovascular Research 45:1019–1025.PubMedCrossRefGoogle Scholar
  113. Zhu J, Shearer GTM, Norman JE, et al., 2000, Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: gender-based differences in inflammation and type of immune response. Circulation 102:2491–2496.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Aristo Vojdani
    • 1
    • 2
  • Edwin L. Cooper
    • 1
  1. 1.Laboratory of Comparative Neuroimmunology, Department of Neurobiology, David Geffen School of Medicine at UCLAUniversity of California, Los AngelesLos AngelesUSA
  2. 2.Section of NeuroimmunologyImmunosciences Lab., Inc.Beverly HillsUSA

Personalised recommendations